Healthcare Industry News: Allograft
News Release - February 7, 2006
Tutogen Medical, Inc. Appoints L. Robert Johnston, Jr. Chief Financial OfficerALACHUA, Fla., Feb. 7 (HSMN NewsFeed) -- Tutogen Medical, Inc., (Amex: TTG ), a leading manufacturer of sterile biological implant products made from human (Allograft) and animal (xenograft) tissue, today announced that the Board of Directors has appointed Mr. L. Robert Johnston, Jr. as the Company's new Chief Financial Officer. Mr. Johnston has more than 15 years of financial management experience in the biotech and medical products industries.
Prior to joining the Tutogen management team, Mr. Johnston, age 45, served as Chief Financial Officer for Power Medical Interventions, a medical device company specializing in surgical stapling products. Previous to that, Mr. Johnston served as an independent consultant to Pittsburgh Life Sciences Greenhouse where he provided business and financial management advice to more than 10 early stage life sciences companies. Mr. Johnston also served as Executive Vice President and CFO for Cellomics, Inc., a provider of instrumentation for automated cellular analysis for drug discovery for pharmaceutical and biotechnology companies. Additionally, he was Senior Vice President and CFO for Oncormed, Inc., a public genomic/pharmacogenomic company focused in cancer. Over his career, Mr. Johnston has had extensive experience in emerging growth companies. He has been instrumental in completing over 20 equity and debt financings totaling more than $225 million and has helped negotiate and complete multiple strategic corporate transactions. Mr. Johnston received a Bachelor of Arts degree from the University of Virginia and an MBA in Finance from the Colgate Darden Graduate School at the University of Virginia.
Guy L. Mayer, Chief Executive Officer of Tutogen Medical, said, "We are pleased to have a financial executive with the depth of experience that Bob Johnston has acquired over a successful career join Tutogen Medical. As we continue to execute our strategic business plan we will rely on Bob's knowledge and expertise in making critical financial management decisions."
Mr. Johnston succeeds George Lombardi. In fiscal 2005, Tutogen announced the integration of its West Paterson, New Jersey corporate offices into its headquarters in Alachua, Florida. In that regard, Mr. Lombardi elected to remain in the New Jersey area and will be resigning his position effective February 15, 2006. Mr. Lombardi will continue to serve as a consultant to the Company as he transitions the CFO responsibilities to Mr. Johnston.
About Tutogen Medical, Inc.
Tutogen Medical, Inc. manufactures sterile biological implant products made from human (Allograft) and animal (xenograft) tissue. Tutogen utilizes its Tutoplast Process® of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company's Tutoplast® products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and Germany. For more information, visit the Company's Web site at http://www.tutogen.com.
Forward Looking Statement Disclaimer: Certain statements in this news release are forward-looking and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, which may differ materially from those set forth in these statements. In addition, the economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission could affect such results. Company's filings with the Securities and Exchange Commission could affect such results.
Source: Tutogen Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.